Ray Sanchez
Ray Sanchez is a senior advisor at Norwest, providing counsel to Norwest’s healthcare portfolio companies in the biotech space. He is a psychiatrist with over 20 years of experience in academic, medical, and pharmaceutical sectors, specializing in CNS, sleep/circadian rhythms, analgesia, and digital health. He was Chief Medical Officer at Cerevel Therapeutics, leading global development […]
Dr. Martin Edwards
Dr. Martin Edwards is a senior advisor at Norwest, providing counsel to Norwest’s healthcare portfolio companies in the biotech space. As a non-executive board member and consultant, Martin currently serves on two US public company boards (Verona and Inozyme) and one US private company (SiteOne). Until September 2023 he was a board member at Reata […]
Norbert Bischofberger, PhD
Norbert Bischofberger, PhD, is a senior advisor at Norwest, providing counsel to Norwest’s healthcare portfolio companies in the biotech space. He is the Chief Executive Officer of NextQuest LLC. He joined Kronos Bio in May 2018, where he served as President and CEO until December 2024. Before his tenure at Kronos Bio, Norbert was the […]
Liz Reifsnyder
Liz is a senior advisor at Norwest, providing counsel to Norwest’s consumer portfolio on all things growth, from consumer-facing channel and product strategy to building organizational capabilities. She brings over a decade of experience in disruptive CPG brands, leading teams and connecting strategy across growth marketing, sales, digital product and engineering, business intelligence, operations and […]
Amalia Mackenzie
Amalia focuses on early-to late-stage venture investments across consumer and enterprise software. Prior to Norwest, Amalia led investments at the intersection of infrastructure and emerging technology as an investor on the Fundamental Equities team at BlackRock. She began her career at Goldman Sachs, within the Technology, Media, and Telecommunications Investment Banking Group, where she executed […]
